Projects

Supported Period: 2013-2015

Supporting Organization:Higher Education Institutions

Project Status: Completed

Supported Period: 2013-2016

Supporting Organization:TÜBİTAK

Project Status: Completed

Supported Period: 2015-2019

Supporting Organization:TÜBİTAK

Project Status: Completed

Supported Period: 2016-2017

Supporting Organization:Higher Education Institutions

Project Status: Completed

Supported Period: 2016-2017

Supporting Organization:Higher Education Institutions

Project Status: Completed

Supported Period: 2018-2019

Supporting Organization:Higher Education Institutions

Project Status: Completed

Supported Period: 2019-2023

Supporting Organization:Higher Education Institutions

Project Status: Completed

Supported Period: 2020-2021

Supporting Organization:TÜSEB

Project Status: Completed

Supported Period: 2021-2022

Supporting Organization:TÜSEB

Project Status: Completed

Supported Period: 2019-

Supporting Organization:Presidential Strategy and Budget Office

Project Status:Ongoing

Supported Period: 2022-

Supporting Organization:Higher Education Institutions Supported Project – Directed

Project Status:Ongoing

Supported Period: 2022-

Supporting Organization:Higher Education Institutions Supported Project – Research Universities

Project Status:Ongoing

Supported Period: 2024-

Supporting Organization:Higher Education Institutions Supported Project – Directed

Project Status:Ongoing

Supported Period: 2023-

Supporting Organization:TÜSEB (Health Institutes of Turkey)

Project Status:Ongoing

Preparation of an inactivated vaccine antigen against Crimean-Congo Hemorrhagic Fever, supported by Higher Education Institutions, conducted from 2013 to 2015.

Investigation of the cellular immune response induced by the inactivated vaccine developed against Crimean-Congo Hemorrhagic Fever, supported by TÜBİTAK, conducted from 2013 to 2016.

Development and efficacy determination of two adenovirus (Ad)-based recombinant vaccine candidates against Crimean-Congo Hemorrhagic Fever, supported by TÜBİTAK, conducted from 2015 to 2019.

Expression and investigation of the biological activity of the nucleoprotein (NP) of Crimean-Congo Hemorrhagic Fever virus in a prokaryotic system, supported by Higher Education Institutions, conducted from 2016 to 2017.

Determination of the stability of hybridoma cell lines developed against the glycoproteins of Crimean-Congo Hemorrhagic Fever virus and investigation of the neutralizing properties of monoclonal antibodies, supported by Higher Education Institutions,

Expression of the non-structural S protein (NSS) of the Crimean-Congo Hemorrhagic Fever virus in a prokaryotic system and investigation of the role of NSS in virus replication, supported by Higher Education Institutions, conducted from 2018 to 2019.

Development of inactivated and adenoviral vector-based vaccine candidates against the COVID-19 UK variant, along with production, purification, and stability analysis of the Crimean-Congo viral vector-based vaccine in HEK-293 cells, supported by a gu

Development of recombinant vaccine candidates against COVID-19, supported by TÜSEB, conducted from 2020 to 2021.

A Phase II placebo-controlled, randomized, double-blind study investigating the efficacy, immunogenicity, and safety of two doses of the inactivated COVID-19 vaccine ERUCOV-VAC, administered intramuscularly to healthy volunteers, supported by TÜSEB.

Establishment of a GMP Laboratory for Phase Studies of Crimean-Congo Hemorrhagic Fever Vaccine

Development of Baculovirus-Based Expression System for Covid-19 and Investigation of its Biological Activity

Project Name: Development of Bivalent and Trivalent Inactivated Vaccines against Covid-19

Formulation, Stabilization, and Evaluation Studies of the Adenovector-Based (Glycoprotein + Nucleoprotein) Vaccine Candidate Developed Against Crimean-Congo Hemorrhagic Fever

Production, Purification, Stability, and Toxicity Studies of the Adenovector-Based Vaccine Candidate (CCHFV Ad-GPC-NP) Developed Against Crimean-Congo Hemorrhagic Fever Virus in Different Cell Lines